Clinical trial NCT03008395 - References

Type2 Diabetes Mellitus — Empowerment, Motivation and Medical Adherence (EMMA).

Citation(s)

•   Aikens JE, Piette JD
  Longitudinal association between medication adherence and glycaemic control in Type 2 diabetes. Diabet Med. 2013 Mar;30(3):338-44. doi: 10.1111/dme.12046.
•   Anderson RM, Funnell MM, Aikens JE, Krein SL, Fitzgerald JT, Nwankwo R, Tannas CL, Tang TS
  Evaluating the Efficacy of an Empowerment-Based Self-Management Consultant Intervention: Results of a Two-Year Randomized Controlled Trial. Ther Patient Educ. 2009 Jun 1;1(1):3-11.
•   Cushing A, Metcalfe R
  Optimizing medicines management: From compliance to concordance. Ther Clin Risk Manag. 2007 Dec;3(6):1047-58.
•   Funnell M
  Beyond the data: moving towards a new DAWN in diabetes. Diabet Med. 2013 Jul;30(7):765-6. doi: 10.1111/dme.12244.
•   Gaede P, Vedel P, Larsen N, Jensen GV, Parving HH, Pedersen O
  Multifactorial intervention and cardiovascular disease in patients with type 2 diabetes. N Engl J Med. 2003 Jan 30;348(5):383-93.
•   Gaver, B, Dunne, T, Pacenti, E
  Design Cultural Probes. Interactions. 1999; 6(1):21-29
•   Grabowski, D, Jensen, BB, Willaing, I, Zoffmann, V, Schiøtz, M
  Sundhedspædagogik in patientuddannelse. A literature-based review of selected health education principles used in patient education. 2010; Steno Diabetes Center
•   Hansen, UM, Engelund, G, à Rogvi, S, Willaing, I (2014)
  The Balancing Person: an innovative approach to person-centered education in chronic illness. The European Journal of Person Centered Healthcare vol 2(3): 290-302
•   Haynes RB, Ackloo E, Sahota N, McDonald HP, Yao X
  Interventions for enhancing medication adherence. Cochrane Database Syst Rev. 2008 Apr 16;(2):CD000011. doi: 10.1002/14651858.CD000011.pub3. Review. Update in: Cochrane Database Syst Rev. 2014;11:CD000011.
•   Ho PM, Rumsfeld JS, Masoudi FA, McClure DL, Plomondon ME, Steiner JF, Magid DJ
  Effect of medication nonadherence on hospitalization and mortality among patients with diabetes mellitus. Arch Intern Med. 2006 Sep 25;166(17):1836-41.
•   Jensen ML, Jørgensen ME, Hansen EH, Aagaard L, Carstensen B
  A multistate model and an algorithm for measuring long-term adherence to medication: a case of diabetes mellitus type 2. Value Health. 2014 Mar;17(2):266-74. doi: 10.1016/j.jval.2013.11.014.
•   Kerse N, Buetow S, Mainous AG 3rd, Young G, Coster G, Arroll B
  Physician-patient relationship and medication compliance: a primary care investigation. Ann Fam Med. 2004 Sep-Oct;2(5):455-61.
•   Kvale,S
  Interviews: an introduction to qualitative research interviewing. 1996. Thousand Oaks, CA; London, Sage
•   Linn AJ, van Weert JC, Schouten BC, Smit EG, van Bodegraven AA, van Dijk L
  Words that make pills easier to swallow: a communication typology to address practical and perceptual barriers to medication intake behavior. Patient Prefer Adherence. 2012;6:871-85. doi: 10.2147/PPA.S36195. Epub 2012 Dec 11.
•   Manca A, Hawkins N, Sculpher MJ
  Estimating mean QALYs in trial-based cost-effectiveness analysis: the importance of controlling for baseline utility. Health Econ. 2005 May;14(5):487-96.
•   Osterberg L, Blaschke T
  Adherence to medication. N Engl J Med 2005; 353(5):487-497 among patients with type 2 diabetes. Diabetologia. 2010; 53(Suppl. 1):1067
•   Peyrot M, Rubin RR
  Behavioral and psychosocial interventions in diabetes: a conceptual review. Diabetes Care. 2007 Oct;30(10):2433-40. Epub 2007 Jul 31. Review.
•   Rhee MK, Slocum Pawson & Tilley
  Realistic Evaluation. 1997. London: Sage
•   Rhee MK, Slocum W, Ziemer DC, Culler SD, Cook CB, El-Kebbi IM, Gallina DL, Barnes C, Phillips LS
  Patient adherence improves glycemic control. Diabetes Educ. 2005 Mar-Apr;31(2):240-50.
•   Richard C, Lussier MT
  MEDICODE: an instrument to describe and evaluate exchanges on medications that occur during medical encounters. Patient Educ Couns. 2006 Dec;64(1-3):197-206. Epub 2006 Jun 16.
•   Skinner TC, Carey ME, Cradock S, Dallosso HM, Daly H, Davies MJ, Doherty Y, Heller S, Khunti K, Oliver L; DESMOND Collaborative
  'Educator talk' and patient change: some insights from the DESMOND (Diabetes Education and Self Management for Ongoing and Newly Diagnosed) randomized controlled trial. Diabet Med. 2008 Sep;25(9):1117-20. doi: 10.1111/j.1464-5491.2008.02492.x.
•   Tang TS, Funnell MM, Gillard M, Nwankwo R, Heisler M
  The development of a pilot training program for peer leaders in diabetes: process and content. Diabetes Educ. 2011 Jan-Feb;37(1):67-77. doi: 10.1177/0145721710387308. Epub 2011 Jan 10.
•   Teasdale, T & Svendsen, H
  Psykologiske & pædagogiske metoder. Kvalitative og kvantitative forskningsmetoder I praksis. Jensen T.B. and Christensen G (eds.). 2005. Frederiksberg:Roskilde Universitetsforla
•   Vallis M
  Behaviour change counselling--how do I know if I am doing it well? The development of the Behaviour Change Counselling Scale (BCCS). Can J Diabetes. 2013 Feb;37(1):18-26. doi: 10.1016/j.jcjd.2013.01.005. Epub 2013 Mar 14.
•   van Dulmen S
  The value of tailored communication for person-centred outcomes. J Eval Clin Pract. 2011 Apr;17(2):381-3. doi: 10.1111/j.1365-2753.2010.01586.x. Epub 2010 Nov 18.
•   Varming, A
  Development and usability of a participatory adherence programme aimed at patients with type 2 diabetes in poor glycemic control. 2012. Master thesis (Master of Drug Management), University of Copenhagen
•   Varming, A
  , Andrésdóttir, G., Engelund, G., Jelstrup, L., Persson, F. I. EMMA: Empowerment, Motivation & Medical Adherence. Dialogue tools for diabetes consultations. ISBN 978-87-92759-07-8. Steno Diabetes Center. 2013 Gentofte.
•   Williams A, Manias E, Walker R
  Interventions to improve medication adherence in people with multiple chronic conditions: a systematic review. J Adv Nurs. 2008 Jul;63(2):132-43. doi: 10.1111/j.1365-2648.2008.04656.x. Review.
•   World Health Organization
  Adherence to long-term therapies: evidence for action. 2003

Empowerment, Motivation and Medical Adherence (EMMA). Dialogue Tools for Consultations With Patients With Type 2 Diabetes

Details for clinical trial NCT03008395